Boenning & Scattergood’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-20,000
| Closed | -$76K | – | 310 |
|
|
2019
Q3 | $76K | Sell |
20,000
-2,500
| -11% | -$9.5K | 0.02% | 265 |
|
|
2019
Q2 | $149K | Sell |
22,500
-12,400
| -36% | -$82.1K | 0.04% | 267 |
|
|
2019
Q1 | $124K | Hold |
34,900
| – | – | 0.04% | 276 |
|
|
2018
Q4 | $138K | Buy |
34,900
+25,350
| +265% | +$100K | 0.05% | 256 |
|
|
2018
Q3 | $189K | Buy |
9,550
+4,800
| +101% | +$95K | 0.06% | 263 |
|
|
2018
Q2 | $151K | Buy |
+4,750
| New | +$151K | 0.05% | 266 |
|